Michael Eyres, Lead Scientist at the Medicines Discovery Catapult (MDC), explores how spatial epigenetics can accelerate biomarker drug discovery.   Epigenetics, once seen as a cryptic mix of marks on our DNA, is now central to our understanding of gene regulation in health and disease. Until recently, we studied epigenetics only in bulk tissues or single cells. But with emerging techniques that reveal its role […]

To read this content in full, you need to login.

Not yet a DDW member? Join now for FREE – it takes less than 2 minutes!